Additional studies in primary and metastatic NB with or without MYCN amplification using single-cell RNA-sequencing showed that while NK cell infiltration can also be high in intermediate- and high-risk NB with amplified MYCN [92, 93], the presence of CD56dim NK cells was not linked to improved clinical outcome [92]. The gene discussed is MYCN; the disease is neuroblastoma.